Skip to main content
SpringerLink
Log in

Differences in NSAID Tolerability Profiles

Fact or Fiction?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Adams SS. Non-steroidal antiinflammatory drugs, plasma half-lives and adverse reactions. Lancet 1: 653–654, 1988

    Article  PubMed  CAS  Google Scholar 

  • Adams SS. The propionic acids: a personal perspective. Journal of Clinical Pharmacology 32: 317–323, 1992

    PubMed  CAS  Google Scholar 

  • Ajodhia JM, Dix MR. Drug-induced deafness and its treatment. Practitioner 216: 561–570, 1976

    PubMed  CAS  Google Scholar 

  • Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. New England Journal of Medicine 327: 749–754, 1992

    Article  PubMed  CAS  Google Scholar 

  • Aronoff GR. Therapeutic implications associated with renal studies of nabumetone. Journal of Rheumatology 19(Suppl. 36): 25–31, 1992

    Google Scholar 

  • Asherov J, Schoenberg A, Weinberger A. Diplopia following ibuprofen administration. Journal of the American Medical Association 248: 649, 1982

    Article  PubMed  CAS  Google Scholar 

  • Bacon P. Worldwide experience with etodalac 300 mg b.i.d. in the treatment of osteoarthritis. Rheumatology International 13 (Suppl.): 7–12, 1993

    Article  Google Scholar 

  • Bailin PL, Matkaluk RM. Cutaneous reactions of rheumatological drugs. Clinics in Rheumatic Diseases 8: 493–516, 1982

    PubMed  CAS  Google Scholar 

  • Bernhard GC. Worldwide safety experience with nabumetone. Journal of Rheumatology 19(Suppl. 36): 48–57, 1992

    Google Scholar 

  • Besinger RE, Niebyl JR, Keyes WG, Johnson TRB. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of pre-term labor. American Journal of Obstetrics and Gynecology 164: 981–988, 1991

    PubMed  CAS  Google Scholar 

  • Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ. Effects of nonsteroidal antiinflammatory drugs on permeability of the small intestine in humans. Journal of Rheumatology 19(Suppl. 36): 83–84, 1992

    Google Scholar 

  • Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ. Importance of local versus systemic effects of nonsteroidal antiinflammatory drugs in increasing small intestinal permeability in man. Gut 32: 275–277, 1991

    Article  PubMed  CAS  Google Scholar 

  • Bjarnason I, Hayllar J, Macpherson AJ, Russell AS. Side effects of nonsteroidal antiinflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832–1847, 1993

    PubMed  CAS  Google Scholar 

  • Bjarnason I, Peters TJ. Intestinal permeability, nonsteroidal antiinflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut Festschrift 30: 22–26, 1989

    Article  Google Scholar 

  • Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Digest of Diseases 4: 83–92, 1986b

    Article  CAS  Google Scholar 

  • Bjarnason I, Prouse P, Smith T, Gumpel MJ, Zanelli G, et al. Blood and protein loss via small-intestinal inflammation induced by nonsteroidal antiinflammatory drugs. Lancet 2: 711–714, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Bjarnason I, So A, Levi AJ, Peters TJ, Williams P, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of nonsteroidal antiinflammatory drugs. Lancet 2: 1171–1173, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bjarnason I, Zanelli G, Prouse P, Williams P, Gumpel MJ, et al. Effect of nonsteroidal antiinflammatory drugs on the human small intestine. Drugs 32(Suppl. 1): 35–41, 1986a

    Article  PubMed  Google Scholar 

  • Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of nonsteroidal antiinflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 27: 1292–1297, 1987a

    Article  Google Scholar 

  • Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, et al. Nonsteroidal antiinflammatory drug induced intestinal inflammation in humans. Gastroenterology 93: 480–489, 1987d

    PubMed  CAS  Google Scholar 

  • Bjarnason I, Zanelli G, Smith T, Smethurst P, Price AB, et al. The pathogenesis and consequence of nonsteroidal antiinflammatory drug induced small intestinal inflammation in man. Scandinavian Journal of Rheumatology (Suppl. 64): 55–62, 1987c

    Google Scholar 

  • Blower PR. The unique pharmacologic profile of nabumetone. Journal of Rheumatology 19(Suppl. 36): 13–19, 1992

    Google Scholar 

  • Bluefarb SM, Holt L. Erythema multiforme bullosum following phenylbutazone therapy. Illinois Medical Journal 107: 37–39, 1955

    PubMed  CAS  Google Scholar 

  • Borda IT. The spectrum of adverse gastrointestinal effects associated with nonsteroidal antiinflammatory drugs. In Borda & Koff (Eds) NSAIDs: a profile of adverse effects, pp. 25–80, Hanley & Belfus Inc., Philadelphia, 1992

    Google Scholar 

  • Brogden RN. Nonsteroidal antiinflammatory analgesics other than salicylates. Drugs 32: 27–45, 1986

    Article  PubMed  Google Scholar 

  • Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs — differences and similarities. New England Journal of Medicine 324: 1716–1725, 1991

    Article  PubMed  CAS  Google Scholar 

  • Bunning RD, Barth WF. Sulindac, a potentially renal-sparing nonsteroidal antiinflammatory drug. Journal of the American Medical Association 248: 2864–2867, 1982

    Article  PubMed  CAS  Google Scholar 

  • Burns CA. Indomethacin, reducing retinal sensitivity, and corneal deposits. American Journal of Ophthalmology 66: 825–835, 1968

    PubMed  CAS  Google Scholar 

  • Carlan SJ, O’Brien WF, O’Leary TD, Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for treatment of refractory pre-term labour. Obstetrics and Gynecology 79: 223–228, 1992

    PubMed  CAS  Google Scholar 

  • Carney MWP. Paranoid psychosis with indomethacin. British Medical Journal 2: 994–995, 1977

    Article  PubMed  CAS  Google Scholar 

  • Carr RE, Siegel IM. Retinal function in patients treated with indomethacin. American Journal of Ophthalmology 75: 302–306, 1973

    PubMed  CAS  Google Scholar 

  • Carson JL, Strom BL, Soper KA, West SL, Morse L, et al. The association of nonsteroidal antiinflammatory drugs with upper gastrointestinal tract bleeding. Archives of Internal Medicine 114: 85–88, 1987a

    Article  Google Scholar 

  • Carson JL, Strom BL, Morse ML, West SL, Soper KA, et al. The relative gastrointestinal toxicity of the nonsteroidal antiinflammatory drugs. Archives of Internal Medicine 147: 1054–1057, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Challis JRG, Patrick JE. The production of prostaglandins and thromboxanes in the feto-placental unit and their effects on the developing fetus. Seminars in Perinatology 4: 23–33, 1980

    PubMed  CAS  Google Scholar 

  • Chalmers TC, Berrier J, Hewitt P, et al. Meta-analysis of randomized controlled trials as a method of estimating rare complications of nonsteroidal antiinflammatory drug therapy. Alimentary Pharmacology and Therapeutics (Suppl. 2): 9–26, 1988

    Google Scholar 

  • Chanda JJ, Callan JP. Erythema multiforme and the Stevens-Johnson syndrome. Southern Medical Journal 71: 566–570, 1978

    Article  PubMed  CAS  Google Scholar 

  • Collier DSJ, Pain JA. Nonsteroidal antiinflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 2: 380–382, 1985

    Google Scholar 

  • Collum LM, Bowen DI. Ocular side-effects of ibuprofen. British Journal of Ophthalmology 55: 472–477, 1971

    Article  PubMed  CAS  Google Scholar 

  • Comline RS, Silver M. Recent observations on the undisturbed fetus in utero and its delivery. In Linden (Ed.) Recent advances in physiology, pp 405, Churchill Livingstone, Edinburgh, 1974

    Google Scholar 

  • Committee on Safety of Medicines. Nonsteroidal antiinflammatory drugs and serious gastrointestinal advances reactions — 2. British Medical Journal 292: 1190–1191, 1986

    Article  Google Scholar 

  • Cone RB, Hannigan CA, Teicher R. Erythema multiforme bollusum following phenylbutazone treatment for arthritis. Archives of Dermatology and Syphiliology 69: 674–677, 1954

    Article  CAS  Google Scholar 

  • Cremona-Barbaro A. Extrapyramidal symptoms following mefanamic acid. Journal of the Royal Society of Medicine 76: 435, 1983

    PubMed  CAS  Google Scholar 

  • De Caterina R, Giannessi D, Lazzerini G, Filipponi P, Mannarelli C, et al. Effect of nabumetone on metabolism of renal arachidonate in humans. Journal of Rheumatology 19(Suppl. 36): 80, 1992

    Google Scholar 

  • Diffey BL, Daymond TJ, Fairgreaves H. Phototoxic reactions to Piroxicam, naproxen and tiaprofenic acid. British Journal of Rheumatology 22: 239–242, 1983

    Article  PubMed  CAS  Google Scholar 

  • Duggan DE, Hare LE, Ditzler TA, Lei BW, Kwan KC. The disposition of sulindac. Clinical Pharmacology and Therapeutics 21: 326–335, 1977

    PubMed  CAS  Google Scholar 

  • Dux S, Groslop I, Garty M, Rosenfeld JB. Anaphylactic shock induced by diclofenac. British Medical Journal 286: 1861, 1983

    Article  PubMed  CAS  Google Scholar 

  • Epstein AM, Read JL, Winickoff R. Physicians beliefs, attitudes, and prescribing behavior for antiinflammatory drugs. American Journal of Medicine 77: 313–318, 1984

    Article  PubMed  CAS  Google Scholar 

  • Finklestein A, Fraley DS, Stachura I, Feldman HA, Gandy DR, et al. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. American Journal of Medicine 72: 81–87, 1982

    Article  Google Scholar 

  • Fries JF. NSAID gastropathy: epidemiology. Journal of Musculoskeletal Medicine 8: 21–28, 1991a

    Google Scholar 

  • Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. Journal of Rheumatology 28 (Suppl.): 6–10, 1991b

    PubMed  CAS  Google Scholar 

  • Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis and Rheumatism 34: 1353–1360, 1991

    Article  PubMed  CAS  Google Scholar 

  • Furst DE. Clinical significance of long versus short serum half-life in NSAIDs. Confounding and complicating factors. In Famaey & Paulus (Eds) Therapeutic applications of NSAIDs. Subpopulations and new formulations, pp. 359–372, Marcel Dekker Inc., New York, 1992

    Google Scholar 

  • Garella S, Matarese RA. Renal effects of prostaglandins and the clinical adverse effects of nonsteroidal antiinflammatory agents. Medicine 63: 165–181, 1984

    Article  PubMed  CAS  Google Scholar 

  • Giercksky KE, Huseby G, Rugstad HE. Epidemiology of NSAID-related gastrointestinal side effects. Scandinavian Journal of Gastroenterology 24(Suppl. 163): 3–8, 1989

    Article  Google Scholar 

  • Goldenberg RL, Davis RO, Baker RC. Indomethacin-induced oligohydramnios. American Journal of Obstetrics and Gynecology 160: 1196–1197, 1989

    PubMed  CAS  Google Scholar 

  • Gotz V. Paranoid psychosis with indomethacin. British Medical Journal 1: 49, 1978

    Article  PubMed  CAS  Google Scholar 

  • Griffin MR, Piper JM, Daughtery J, Snowden M, Ray WA, et al. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Annals of Internal Medicine 114: 257–263, 1991

    PubMed  CAS  Google Scholar 

  • Griffith JD, Smith CH, Smith RC. Paranoid psychosis in a patient receiving ibuprofen, a prostaglandin synthesis inhibitor: case report. Journal of Clinical Psychiatry 43: 499–500, 1982

    PubMed  CAS  Google Scholar 

  • Hamzlik PJ, Scott RW, Reycraft JL. The salicylates. VIII. Salicylate edema. Archives of Internal Medicine 20: 329–340, 1917

    Article  Google Scholar 

  • Hayllar JA, Macpherson A, Bjarnason I. Gastroprotection and nonsteroidal antiinflammatory drugs (NSAIDs). Drug Safety 7: 86–105, 1992

    Article  PubMed  CAS  Google Scholar 

  • Helftott SM, Sandberg-Cook J, Zakim D, Nestler J. Diclofenac associated hepatitis. Journal of the American Medical Association 264: 2660–2662, 1990

    Article  Google Scholar 

  • Henry DA, Dobson A, Turner K, et al. Non-steroidal anti-inflammatory drugs and the risk of upper gastrointestinal bleeding. Correspondence. Lancet 337: 730, 1991

    Article  PubMed  CAS  Google Scholar 

  • Henry DA, Robertson J, Lawson DH. Pharmacoepidemiology of nonsteroidal antiinflammatory drugs. In Borda & Koff (Eds) NSAIDs: a profile of adverse effects, pp. 1–23, Hanley & Belfus Inc., Philadelphia, 1992

    Google Scholar 

  • Heymann MA. Non-narcotic analgesics: use in pregnancy and fetal and perinatal effects. Drugs 32(Suppl. 4): 164–176, 1986

    Article  PubMed  Google Scholar 

  • Hickok DE, Hollenbach KA, Reilly SF, Nyberg DA. The association between decreased amniotic fluid volume and treatment with nonsteroidal antiinflammatory drugs for pre-term labor. American Journal of Obstetrics and Gynecology 160: 723–728, 1989

    Google Scholar 

  • Hochberg MC. Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations. Journal of Rheumatology 16(Suppl. 36): 63–67, 1992

    Google Scholar 

  • Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Archives of Internal Medicine 151: 1309–1313, 1991

    Article  PubMed  CAS  Google Scholar 

  • Inman WH. Study of fatal bone marrow depression with special referene to phenylbutazone and oxyphenbutazone. British Medical Journal 1: 1500–1505, 1977

    Article  PubMed  CAS  Google Scholar 

  • International Agranulocytosis and Aplastic Anemia Study Group. Journal of the American Medical Association 256: 1749–1757, 1986

    Article  Google Scholar 

  • Jenkins AP, Trew AJ, Crump BJ, Nukajam WS, Foley JA, et al. Do nonsteroidal antiinflammatory drugs increase colonic permeability? Gut 32: 66–69, 1991

    Article  PubMed  CAS  Google Scholar 

  • Jenkins RT, Rooney PJ, Jones DB, Bienenstock J, Goodacre RL. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal antiinflammatory drug therapy? British Journal of Rheumatology 26: 103–107, 1987

    Article  PubMed  CAS  Google Scholar 

  • Johnson P. Suppression of preterm labour: current concepts. Drugs 45: 684–692, 1993

    Article  PubMed  CAS  Google Scholar 

  • Kimberley RP, Plotz PH. Aspirin-induced depression of renal function. New England Journal of Medicine 296: 418–424, 1977

    Article  Google Scholar 

  • Kirshon B, Moise KJ, Wasserstrum N, Ou CN, Huhta JC. Influence of short-term indomethacin therapy on fetal urine output. Obstetrics and Gynecology 72: 51–53, 1988

    PubMed  CAS  Google Scholar 

  • Kruis R, Barger R. Paranoid psychosis with sulindac. Journal of the American Medical Association 243: 1630–1631, 1980

    Article  Google Scholar 

  • Kuokkanen K. Drug eruptions: a series of 464 cases in the Department of Dermatology, University of Turku, Finland during 1966–1970. Acta Allergologica 27: 407–438, 1972

    PubMed  CAS  Google Scholar 

  • Lanza F, Rack MF, Lynn M, Wolf J, Sanda M. An endoscopic comparison of the effects of etodolac, indomethacin, naproxen, and placebo on the gastrointestinal mucosa. Journal of Rheumatology 14: 338–341, 1987

    PubMed  CAS  Google Scholar 

  • Laporte JR, Carne X, Vidal X, Moreno V, Juan J, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal antiinflammatory drugs. Lancet 337: 85–89, 1991

    Article  PubMed  CAS  Google Scholar 

  • Levinson JE, Baum J, Brewer E, Fink C, Hanson V, et al. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. Journal of Pediatrics 91: 799–804, 1977

    Article  PubMed  CAS  Google Scholar 

  • Lewis RB, Schulman JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 2: 1159–1161, 1973

    Article  PubMed  CAS  Google Scholar 

  • Maberly DJ, Greenhalgh RM. Jaundice and exfoliative dermatitis due to phenylbutazone. British Journal of Dermatology 82: 618–610, 1970

    Article  PubMed  CAS  Google Scholar 

  • Manso C, Taranta A, Nydick I. Effect of aspirin administration on serum glutamic oxaloacetic and glutamic pyruvic transaminases in children. Proceedings of the Society of Experimental Biological Medicine 93: 84–88, 1956

    CAS  Google Scholar 

  • Mauer EE. The toxic effects of phenylbutazone (Butazolidin). Review of the literature and report of the twenty-third death following its use. New England Journal of Medicine 253: 404–410, 1955

    Article  PubMed  CAS  Google Scholar 

  • Merot Y, Harms M, Saurat JH. Photosensibilisation au carprofene (Imadyl), une nouvelle anti-inflammatoire non steroidien. Dermatologica 166: 301–307, 1983

    Article  PubMed  CAS  Google Scholar 

  • Merritt GJ, Selle RI. Cross-reactivity between aspirin and ibuprofen in an asthmatic — a case report. American Journal of Hospital Pharmacy 35: 1245–1248, 1978

    PubMed  CAS  Google Scholar 

  • Miller RR. Deafness due to plain and long-acting aspirin tablets. Journal of Clinical Pharmacology 18: 468–471, 1978

    PubMed  CAS  Google Scholar 

  • Mongan E, Kelly P, Nies K. Tinnitus as an indication of therapeutic salicylate levels. Journal of the American Medical Association 226: 142–145, 1973

    Article  PubMed  CAS  Google Scholar 

  • Montgomery PR. Toxic epidermal necrolysis due to phenylbutazone. British Journal of Dermatology 83: 220, 1970

    Article  Google Scholar 

  • Morris EL, Hochberg MC, Dorsch CA. Agranulocytosis and sulindac. Arthritis and Rheumatism 24: 752–753, 1981

    Article  PubMed  CAS  Google Scholar 

  • Murray MD, Brater DC. Renal toxicity of nonsteroidal antiinflammatory drugs. Annual Review of Pharmacology and Toxicology 33: 435–465, 1993

    Article  PubMed  CAS  Google Scholar 

  • Myers EN, Bernstein JM, Forstiropolous G. Salicylate ototoxicity. New England Journal of Medicine 273: 587–590, 1965

    Article  PubMed  CAS  Google Scholar 

  • McNeil JR. The possible teratogenic effects of salicylates on the developing fetus. Brief summaries of eight suggestive cases. Clinical Pediatrics 12: 347–350, 1973

    Google Scholar 

  • Nydick I, Tang J, Stollerman GH, Wroblewski F, LaDue JS. The influence of rheumatic fever on serum concentrations of the enzyme glutamic oxaloacetic transaminase. Circulation 12: 795–806, 1955

    Article  PubMed  CAS  Google Scholar 

  • O’Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal antiinflammatory drugs. Journal of Rheumatology 12: 785–790, 1985b

    PubMed  Google Scholar 

  • O’Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal antiinflammatory drugs. Journal of Rheumatology 12: 13–20, 1985a

    PubMed  Google Scholar 

  • Palimeris G, Koliopoulos J, Velissaropoulos P. Ocular side effects of indomethacin. Opthalmologica 164: 339–353, 1972

    Article  CAS  Google Scholar 

  • Palmer CAL. Toxic amblyopia from ibuprofen. British Medical Journal 3: 765, 1972

    Article  PubMed  CAS  Google Scholar 

  • Powell D. Barrier function of epithelia. Americal Journal of Physiology 241: G275–G288, 1981

    CAS  Google Scholar 

  • Puddey IB, Berlin LJ, Vandogen R, Banks R, Rouse I. Differential effects of sulindac and indomethacin on blood pressure in treated essential hypertensive subjects. Clinical Sciences 69: 327–336, 1985

    CAS  Google Scholar 

  • Quintero E, Gines P, Arroyo V, Rimola A, Camps J, et al. Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 42: 298–303, 1986

    Article  PubMed  CAS  Google Scholar 

  • Rampton DS. Nonsteroidal antiinflammatory drugs and the lower gastrointestinal tract. Scandinavian Journal of Gastroenterology 22: 1–4, 1987

    Article  PubMed  CAS  Google Scholar 

  • Redmond AD. Dyskinesia induced by mefanamic acid? Journal of the Royal Society of Medicine 74: 558–559, 1981

    PubMed  CAS  Google Scholar 

  • Restivo C, Paulus HE. Anaphylaxis from tolmetin. Journal of the American Medical Association 240: 246, 1978

    Article  PubMed  CAS  Google Scholar 

  • Ritland S. Stevens-Johnson syndrome etter behandling med Tanderil. Tidskkrift For Den Norske Laegeforening 88: 2021–2022, 1968

    CAS  Google Scholar 

  • Roberts DG, Gerber JG, Barnes JS, Zerbe GO, Nies AS. Sulindac is not renal sparing in man. Clinical Pharmacology and Therapeutics 38: 258–265, 1985

    Article  PubMed  CAS  Google Scholar 

  • Robertson RT, Allen HL, Bokelman DL. Aspirin: teratogenic evaluation in the dog. Teratology 20: 313–317, 1979

    Article  PubMed  CAS  Google Scholar 

  • Robinson R. Indomethacin in rheumatoic diseases: a clinical assessment. Medical Journal of Australia 1: 226–269, 1965

    Google Scholar 

  • Rodack K, Deck C. Do nonsteroidal antiinflammatory drugs interfere with blood pressure control in hypertensive patients? Journal of General Internal Medicine 2: 108–112, 1987

    Article  Google Scholar 

  • Roth SH. Upper gastrointestinal safety with nabumetone. Journal of Rheumatology 19(Suppl. 36): 74–79, 1992

    Google Scholar 

  • Rurak DW, Wright MR, Axelson JE. Drug disposition and effects in the fetus. Journal of Developmental Physiology 15: 33–44, 1991

    PubMed  CAS  Google Scholar 

  • Russell AS, Sturge RA, Smith MA. Serum transaminases during salicylate therapy. British Medical Journal 2: 428–429, 1971

    Article  PubMed  CAS  Google Scholar 

  • Russell RI. Endoscopie evaluation of etodolac and naproxen, and their relative effects on gastric and duodenal prostaglandins. Rheumatology International 10: 17–21, 1990

    Article  PubMed  Google Scholar 

  • Sager DS, Bennett RM. Individualizing the risk/benefit ratio of NSAIDs in older patients. Geriatrics 47. 24–31, 1992

    PubMed  CAS  Google Scholar 

  • Sakai J, Joseph MW. Tolmetin and agranulocytosis. New England Journal of Medicine 298: 1203, 1978

    PubMed  CAS  Google Scholar 

  • Salom I, Jacob G, Jallad N, Perdomo CA, Mullane JF, et al. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin and naproxen in normal males. Journalof Clinical Pharmacology 24: 240–246, 1984

    CAS  Google Scholar 

  • Sandyk R, Awerbuch G, Rapcsak SZ. Bilateral ballism induced by ibuprofen in a schizophrenic patient. Postgraduate Medical Journal 63: 593–594, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sandford-Smith JH. Transient myopia after aspirin. British Journal of Opthalmology 58: 698–700, 1974

    Article  CAS  Google Scholar 

  • Sandyk R, Gillman MA. Acute exacerbation of Parkinson’s disease with sulindac. Annuals of Neurology 17: 104–105, 1987

    Article  Google Scholar 

  • Schaller JG. Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin ‘hepatitis’ and its clinical significance. Paediatrics 62: 916–925, 1978

    CAS  Google Scholar 

  • Schattenkirchner M. An updated safety profile of etodolac in several thousand patients. European Journal of Rheumatology and Inflammation 10: 56–65, 1990

    PubMed  CAS  Google Scholar 

  • Schattenkirchner M. The safety profile of sustained-release etodolac. Rheumatology International 13 (Suppl.): 31–35, 1993

    Article  Google Scholar 

  • Smith FE, Lindberg PJ. Life-threatening hypersensitivity to sulindac. Journal of the American Medical Association 244: 269–270, 1980

    Article  PubMed  CAS  Google Scholar 

  • Steel SJ, Moffatt JL. Stevens-Johnson syndrome and granulocytopenia after phenylbutazone. British Medical Journal 1: 795, 1954

    Article  PubMed  CAS  Google Scholar 

  • Stern RS. Phototoxic reactions to piroxicam and other nonsteroidal antiinflammatory agents. New England Journal of Medicine 309: 186–187, 1983

    PubMed  CAS  Google Scholar 

  • Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal antiinflammatory drugs: reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. Journal of the American Medical Association 252: 1433–1437, 1984

    Article  PubMed  CAS  Google Scholar 

  • Stevenson BR, Anderson MA, Bullivant S. The epithelial tight junction: structure, function and prelimary biochemical characterization. Molecular and Cellular Biochemistry 83: 129–145, 1988

    Article  PubMed  CAS  Google Scholar 

  • Szeto HH, Mann LI, Bhakthavathsalan A, Lui M, Inturrisi CE. Meperidine kinetics in the maternal-fetal unit. Journal of Experimental Pharmacology and Therapeutics 206: 448–459, 1978

    CAS  Google Scholar 

  • Taggart HM, Aderdice JM. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. British Medical Journal 284: 1372, 1982

    Article  PubMed  CAS  Google Scholar 

  • Taylor KPA, Rothermich NO. Deafness and hand tremor with indomethacin. Journal of the American Medical Association 226: 1471–1472, 1973

    Article  Google Scholar 

  • Thompson M. Toxic amblyopia from ibuprofen. British Medical Journal 4: 550, 1972

    Article  PubMed  CAS  Google Scholar 

  • Tullio CJ. Ibuprofen-induced visual disturbances. American Journal of Hospital Pharmacology 38: 1362, 1981

    CAS  Google Scholar 

  • Turner G, Collins E. Fetal effects of regular salicylate ingestion in pregnancy. Lancet 2: 338–339, 1975

    Article  PubMed  CAS  Google Scholar 

  • Turner R. Hepatic and renal tolerability of long term naproxen treatment in patients with rheumatoid arthritis. Seminars in Arthritis and Rheumatism 17: 29–35, 1988

    Article  PubMed  CAS  Google Scholar 

  • Umez-Eronini EM. Conjunctivitis due to ketoprofen. Lancet 2: 737, 1978

    Article  PubMed  CAS  Google Scholar 

  • van Joost T, Asghar SS, Cormane RH. Skin reactions caused by phenylbutazone: immunologic studies. Archives of Dermatology 110: 929–933, 1974

    Article  PubMed  Google Scholar 

  • van Petten GR, Mathison HJ, Harris WH, Mears GJ. Chronic preparation of the pregnant ewe and fetus for pharmacological research: the placental transfer and fetal effects of bunitrolol. Journal of Pharmacological Methods 1: 45–60, 1978

    Article  Google Scholar 

  • Willkens RF. The selection of a nonsteroidal antiinflammatory drug. Is there a difference? Journal of Rheumatology 19(Suppl. 36): 9–12, 1992

    Google Scholar 

  • Wilson JG, Ritter EJ, Scott WJ, Fradkin R. Comparative distribution and embryotoxicity of acetylsalicylic acid in pregnant rats and rhesus monkeys. Toxicology and Applied Pharmacology 41: 67–78, 1977

    Article  PubMed  CAS  Google Scholar 

  • Wood N, Pall HS, Williams AC, Dieppe C. Extrapyramidal reactions to antiinflammatory drugs. Journal Neurology and Neurosurgical Psychiatry 51: 731–732, 1988

    Article  CAS  Google Scholar 

  • Zeidler H. Epidemiology of NSAID induced gastropathy. Journal of Rheumatology 18(Suppl. 28): 1–5, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatic Disease Unit, Department of Medicine, University of Alberta, 562 Heritage Medical Research Bldg, Edmonton, Alberta, Canada, T6G 2S2

    Kenneth J. Skeith &  Paul Davis

  2. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

    Kenneth J. Skeith & Matthew Wright

Authors
  1. Kenneth J. Skeith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skeith, K.J., Wright, M. & Davis, P. Differences in NSAID Tolerability Profiles. Drug-Safety 10, 183–195 (1994). https://doi.org/10.2165/00002018-199410030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199410030-00001

Keywords

Search

Navigation